SUPERNUS PHARMACEUTICALS, INC. (SUPN) Gross profit 2016–2025
SUPERNUS PHARMACEUTICALS, INC. (SUPN) annual gross profit history from SEC filings — each fiscal year as reported.
$644.4MFY2025 · since FY2016: $203.0M → $644.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $644.4M | +10.4% |
| FY2024 | $583.9M | +11.5% |
| FY2023 | $523.7M | -9.7% |
| FY2022 | $580.0M | — |
| FY2020 | $467.9M | +24.4% |
| FY2019 | $376.1M | -4.4% |
| FY2018 | $393.5M | +37.1% |
| FY2017 | $287.0M | +41.4% |
| FY2016 | $203.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice